ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Quetiapine Fumarate Sustained Release Tablets Market Research Report 2026
Published Date: 2026-03-11
|
Report Code: QYRE-Auto-24G17630
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Quetiapine Fumarate Sustained Release Tablets Market Research Report 2024
BUY CHAPTERS

Global Quetiapine Fumarate Sustained Release Tablets Market Research Report 2026

Code: QYRE-Auto-24G17630
Report
2026-03-11
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Teva Pharmaceutical Industries
Dr. Reddy’s Laboratories
Sun Pharmaceutical Industries
Mylan N.V.
Torrent Pharmaceuticals
Lupin Ltd
Sandoz Inc
Luye Pharma Limited
PHARMATHEN INVESTMENTS GROUP LIMITED
Seroquel

Quetiapine Fumarate Sustained Release Tablets Market

The global Quetiapine Fumarate Sustained Release Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Quetiapine Fumarate Sustained Release Tablets is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Quetiapine Fumarate Sustained Release Tablets is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Quetiapine Fumarate Sustained Release Tablets in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Quetiapine Fumarate Sustained Release Tablets include Luye Pharma Limited, PHARMATHEN INVESTMENTS GROUP LIMITED, Seroquel, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, Mylan N.V., Torrent Pharmaceuticals, Lupin Limited, Sandoz, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Quetiapine Fumarate Sustained Release Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Quetiapine Fumarate Sustained Release Tablets. The Quetiapine Fumarate Sustained Release Tablets market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Quetiapine Fumarate Sustained Release Tablets market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Quetiapine Fumarate Sustained Release Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Quetiapine Fumarate Sustained Release Tablets Market Report

Report Metric Details
Report Name Quetiapine Fumarate Sustained Release Tablets Market
Segment by Type
  • 50mg
  • 200mg
  • 300mg
  • 400mg
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Luye Pharma Limited, PHARMATHEN INVESTMENTS GROUP LIMITED, Seroquel, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, Mylan N.V., Torrent Pharmaceuticals, Lupin Limited, Sandoz
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Quetiapine Fumarate Sustained Release Tablets companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Quetiapine Fumarate Sustained Release Tablets Market report?

Ans: The main players in the Quetiapine Fumarate Sustained Release Tablets Market are Luye Pharma Limited, PHARMATHEN INVESTMENTS GROUP LIMITED, Seroquel, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, Mylan N.V., Torrent Pharmaceuticals, Lupin Limited, Sandoz

What are the Application segmentation covered in the Quetiapine Fumarate Sustained Release Tablets Market report?

Ans: The Applications covered in the Quetiapine Fumarate Sustained Release Tablets Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Quetiapine Fumarate Sustained Release Tablets Market report?

Ans: The Types covered in the Quetiapine Fumarate Sustained Release Tablets Market report are 50mg, 200mg, 300mg, 400mg

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 50mg
1.2.3 200mg
1.2.4 300mg
1.2.5 400mg
1.3 Market by Application
1.3.1 Global Quetiapine Fumarate Sustained Release Tablets Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Perspective (2021–2032)
2.2 Global Quetiapine Fumarate Sustained Release Tablets Growth Trends by Region
2.2.1 Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Quetiapine Fumarate Sustained Release Tablets Historic Market Size by Region (2021–2026)
2.2.3 Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Region (2027–2032)
2.3 Quetiapine Fumarate Sustained Release Tablets Market Dynamics
2.3.1 Quetiapine Fumarate Sustained Release Tablets Industry Trends
2.3.2 Quetiapine Fumarate Sustained Release Tablets Market Drivers
2.3.3 Quetiapine Fumarate Sustained Release Tablets Market Challenges
2.3.4 Quetiapine Fumarate Sustained Release Tablets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Quetiapine Fumarate Sustained Release Tablets Players by Revenue
3.1.1 Global Top Quetiapine Fumarate Sustained Release Tablets Players by Revenue (2021–2026)
3.1.2 Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Players (2021–2026)
3.2 Global Top Quetiapine Fumarate Sustained Release Tablets Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Quetiapine Fumarate Sustained Release Tablets Revenue
3.4 Global Quetiapine Fumarate Sustained Release Tablets Market Concentration Ratio
3.4.1 Global Quetiapine Fumarate Sustained Release Tablets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Quetiapine Fumarate Sustained Release Tablets Revenue in 2025
3.5 Global Key Players of Quetiapine Fumarate Sustained Release Tablets Head Offices and Areas Served
3.6 Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Products and Applications
3.7 Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Quetiapine Fumarate Sustained Release Tablets Breakdown Data by Type
4.1 Global Quetiapine Fumarate Sustained Release Tablets Historic Market Size by Type (2021–2026)
4.2 Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Type (2027–2032)
5 Quetiapine Fumarate Sustained Release Tablets Breakdown Data by Application
5.1 Global Quetiapine Fumarate Sustained Release Tablets Historic Market Size by Application (2021–2026)
5.2 Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
6.2 North America Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021–2026)
6.4 North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
7.2 Europe Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021–2026)
7.4 Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
8.2 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2021–2026)
8.4 Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
9.2 Latin America Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021–2026)
9.4 Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size (2021–2032)
10.2 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2021–2026)
10.4 Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Luye Pharma Limited
11.1.1 Luye Pharma Limited Company Details
11.1.2 Luye Pharma Limited Business Overview
11.1.3 Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Introduction
11.1.4 Luye Pharma Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.1.5 Luye Pharma Limited Recent Development
11.2 PHARMATHEN INVESTMENTS GROUP LIMITED
11.2.1 PHARMATHEN INVESTMENTS GROUP LIMITED Company Details
11.2.2 PHARMATHEN INVESTMENTS GROUP LIMITED Business Overview
11.2.3 PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Introduction
11.2.4 PHARMATHEN INVESTMENTS GROUP LIMITED Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.2.5 PHARMATHEN INVESTMENTS GROUP LIMITED Recent Development
11.3 Seroquel
11.3.1 Seroquel Company Details
11.3.2 Seroquel Business Overview
11.3.3 Seroquel Quetiapine Fumarate Sustained Release Tablets Introduction
11.3.4 Seroquel Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.3.5 Seroquel Recent Development
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Details
11.4.2 Teva Pharmaceutical Industries Business Overview
11.4.3 Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Introduction
11.4.4 Teva Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.4.5 Teva Pharmaceutical Industries Recent Development
11.5 Dr. Reddy's Laboratories
11.5.1 Dr. Reddy's Laboratories Company Details
11.5.2 Dr. Reddy's Laboratories Business Overview
11.5.3 Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Introduction
11.5.4 Dr. Reddy's Laboratories Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.5.5 Dr. Reddy's Laboratories Recent Development
11.6 Sun Pharmaceutical Industries
11.6.1 Sun Pharmaceutical Industries Company Details
11.6.2 Sun Pharmaceutical Industries Business Overview
11.6.3 Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Introduction
11.6.4 Sun Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.6.5 Sun Pharmaceutical Industries Recent Development
11.7 Mylan N.V.
11.7.1 Mylan N.V. Company Details
11.7.2 Mylan N.V. Business Overview
11.7.3 Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Introduction
11.7.4 Mylan N.V. Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.7.5 Mylan N.V. Recent Development
11.8 Torrent Pharmaceuticals
11.8.1 Torrent Pharmaceuticals Company Details
11.8.2 Torrent Pharmaceuticals Business Overview
11.8.3 Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Introduction
11.8.4 Torrent Pharmaceuticals Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.8.5 Torrent Pharmaceuticals Recent Development
11.9 Lupin Limited
11.9.1 Lupin Limited Company Details
11.9.2 Lupin Limited Business Overview
11.9.3 Lupin Limited Quetiapine Fumarate Sustained Release Tablets Introduction
11.9.4 Lupin Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.9.5 Lupin Limited Recent Development
11.10 Sandoz
11.10.1 Sandoz Company Details
11.10.2 Sandoz Business Overview
11.10.3 Sandoz Quetiapine Fumarate Sustained Release Tablets Introduction
11.10.4 Sandoz Revenue in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
11.10.5 Sandoz Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Teva Pharmaceutical Industries
Dr. Reddy’s Laboratories
Sun Pharmaceutical Industries
Mylan N.V.
Torrent Pharmaceuticals
Lupin Ltd
Sandoz Inc
Luye Pharma Limited
PHARMATHEN INVESTMENTS GROUP LIMITED
Seroquel
List of Tables
 Table 1. Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of 50mg
 Table 3. Key Players of 200mg
 Table 4. Key Players of 300mg
 Table 5. Key Players of 400mg
 Table 6. Global Quetiapine Fumarate Sustained Release Tablets Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2021–2026)
 Table 10. Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2027–2032)
 Table 12. Quetiapine Fumarate Sustained Release Tablets Market Trends
 Table 13. Quetiapine Fumarate Sustained Release Tablets Market Drivers
 Table 14. Quetiapine Fumarate Sustained Release Tablets Market Challenges
 Table 15. Quetiapine Fumarate Sustained Release Tablets Market Restraints
 Table 16. Global Quetiapine Fumarate Sustained Release Tablets Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Players (2021–2026)
 Table 18. Global Top Quetiapine Fumarate Sustained Release Tablets Players by Tier (Tier 1, Tier 2, and Tier 3), based on Quetiapine Fumarate Sustained Release Tablets Revenue, 2025
 Table 19. Ranking of Global Top Quetiapine Fumarate Sustained Release Tablets Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Quetiapine Fumarate Sustained Release Tablets Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Headquarters and Area Served
 Table 22. Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Products and Applications
 Table 23. Global Key Players of Quetiapine Fumarate Sustained Release Tablets, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Type (2021–2026)
 Table 27. Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Type (2027–2032)
 Table 29. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Application (2021–2026)
 Table 31. Global Quetiapine Fumarate Sustained Release Tablets Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Quetiapine Fumarate Sustained Release Tablets Revenue Market Share by Application (2027–2032)
 Table 33. North America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size by Country (US$ Million), 2027–2032
 Table 48. Luye Pharma Limited Company Details
 Table 49. Luye Pharma Limited Business Overview
 Table 50. Luye Pharma Limited Quetiapine Fumarate Sustained Release Tablets Product
 Table 51. Luye Pharma Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
 Table 52. Luye Pharma Limited Recent Development
 Table 53. PHARMATHEN INVESTMENTS GROUP LIMITED Company Details
 Table 54. PHARMATHEN INVESTMENTS GROUP LIMITED Business Overview
 Table 55. PHARMATHEN INVESTMENTS GROUP LIMITED Quetiapine Fumarate Sustained Release Tablets Product
 Table 56. PHARMATHEN INVESTMENTS GROUP LIMITED Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
 Table 57. PHARMATHEN INVESTMENTS GROUP LIMITED Recent Development
 Table 58. Seroquel Company Details
 Table 59. Seroquel Business Overview
 Table 60. Seroquel Quetiapine Fumarate Sustained Release Tablets Product
 Table 61. Seroquel Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
 Table 62. Seroquel Recent Development
 Table 63. Teva Pharmaceutical Industries Company Details
 Table 64. Teva Pharmaceutical Industries Business Overview
 Table 65. Teva Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product
 Table 66. Teva Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
 Table 67. Teva Pharmaceutical Industries Recent Development
 Table 68. Dr. Reddy's Laboratories Company Details
 Table 69. Dr. Reddy's Laboratories Business Overview
 Table 70. Dr. Reddy's Laboratories Quetiapine Fumarate Sustained Release Tablets Product
 Table 71. Dr. Reddy's Laboratories Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
 Table 72. Dr. Reddy's Laboratories Recent Development
 Table 73. Sun Pharmaceutical Industries Company Details
 Table 74. Sun Pharmaceutical Industries Business Overview
 Table 75. Sun Pharmaceutical Industries Quetiapine Fumarate Sustained Release Tablets Product
 Table 76. Sun Pharmaceutical Industries Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
 Table 77. Sun Pharmaceutical Industries Recent Development
 Table 78. Mylan N.V. Company Details
 Table 79. Mylan N.V. Business Overview
 Table 80. Mylan N.V. Quetiapine Fumarate Sustained Release Tablets Product
 Table 81. Mylan N.V. Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
 Table 82. Mylan N.V. Recent Development
 Table 83. Torrent Pharmaceuticals Company Details
 Table 84. Torrent Pharmaceuticals Business Overview
 Table 85. Torrent Pharmaceuticals Quetiapine Fumarate Sustained Release Tablets Product
 Table 86. Torrent Pharmaceuticals Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
 Table 87. Torrent Pharmaceuticals Recent Development
 Table 88. Lupin Limited Company Details
 Table 89. Lupin Limited Business Overview
 Table 90. Lupin Limited Quetiapine Fumarate Sustained Release Tablets Product
 Table 91. Lupin Limited Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
 Table 92. Lupin Limited Recent Development
 Table 93. Sandoz Company Details
 Table 94. Sandoz Business Overview
 Table 95. Sandoz Quetiapine Fumarate Sustained Release Tablets Product
 Table 96. Sandoz Revenue in Quetiapine Fumarate Sustained Release Tablets Business (US$ Million), 2021–2026
 Table 97. Sandoz Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Quetiapine Fumarate Sustained Release Tablets Picture
 Figure 2. Global Quetiapine Fumarate Sustained Release Tablets Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Type: 2025 vs 2032
 Figure 4. 50mg Features
 Figure 5. 200mg Features
 Figure 6. 300mg Features
 Figure 7. 400mg Features
 Figure 8. Global Quetiapine Fumarate Sustained Release Tablets Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Application: 2025 vs 2032
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. Others Case Studies
 Figure 13. Quetiapine Fumarate Sustained Release Tablets Report Years Considered
 Figure 14. Global Quetiapine Fumarate Sustained Release Tablets Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Quetiapine Fumarate Sustained Release Tablets Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Region: 2025 vs 2032
 Figure 17. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Players in 2025
 Figure 18. Global Quetiapine Fumarate Sustained Release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Quetiapine Fumarate Sustained Release Tablets Revenue in 2025
 Figure 20. North America Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021–2032)
 Figure 22. United States Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021–2032)
 Figure 26. Germany Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Quetiapine Fumarate Sustained Release Tablets Market Share by Region (2021–2032)
 Figure 34. China Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021–2032)
 Figure 42. Mexico Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Quetiapine Fumarate Sustained Release Tablets Market Share by Country (2021–2032)
 Figure 46. Israel Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Quetiapine Fumarate Sustained Release Tablets Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Luye Pharma Limited Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
 Figure 50. PHARMATHEN INVESTMENTS GROUP LIMITED Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
 Figure 51. Seroquel Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
 Figure 52. Teva Pharmaceutical Industries Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
 Figure 53. Dr. Reddy's Laboratories Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
 Figure 54. Sun Pharmaceutical Industries Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
 Figure 55. Mylan N.V. Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
 Figure 56. Torrent Pharmaceuticals Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
 Figure 57. Lupin Limited Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
 Figure 58. Sandoz Revenue Growth Rate in Quetiapine Fumarate Sustained Release Tablets Business (2021–2026)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Quetiapine Fumarate API Market Research Report 2024
Global Quetiapine Market Research Report 2025
Global Quetiapine Fumarate Tablets Market Research Report 2024
Global Quetiapine Fumarate Market Insights Forecast to 2030
Bedaquiline Fumarate Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Theophylline Sustained Release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Paliperidone Extended Release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tenofovir Alafenamide Fumarate Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Sustained and Controlled Release Formulations Market Research Report 2025
Global Sustained and Controlled Release Formulations Market Research Report 2025
Cefaclor Sustained Release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Risperidone Oral Tablets Market Research Report 2024
Global Capecitabine Fumarate Market Research Report 2025
Global Doxazosin Mesylate Extended Release Tablets Market Research Report 2024
Fluorouracil Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lafutidine Tablets Market Research Report 2024
Global Lacidipine Tablets Market Research Report 2024
Diclofenac Sodium Sustained release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Formoterol Fumarate API Market Research Report 2025
Global Tenofovir Alafenamide Fumarate Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions